Exact Mass: 460.2461
Exact Mass Matches: 460.2461
Found 500 metabolites which its exact mass value is equals to given mass value 460.2461
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Sophoranone
A dihydroxyflavanone that is (2S)-flavanone substituted by hydroxy groups at positions 7 and 4 and prenyl groups at positions 3 and 5 respectively.
4,4-Diapolycopene-4,4-dioate
1-(8Z,11Z,14Z-eicosatrienoyl)-glycero-3-phosphate
1-(8Z,11Z,14Z-eicosatrienoyl)-glycero-3-phosphate is classified as a member of the 1-acylglycerol-3-phosphates. 1-acylglycerol-3-phosphates are lysophosphatidic acids where the glycerol is esterified with a fatty acid at O-1 position. 1-(8Z,11Z,14Z-eicosatrienoyl)-glycero-3-phosphate is considered to be practically insoluble (in water) and acidic. 1-(8Z,11Z,14Z-eicosatrienoyl)-glycero-3-phosphate is a glycerophosphate lipid molecule
LysoPA(20:3(5Z,8Z,11Z)/0:0)
LysoPA(20:3(5Z,8Z,11Z)/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. LysoPA(20:3(5Z,8Z,11Z)/0:0), in particular, consists of one chain of mead acid at the C-1 position. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes.
LysoPA(20:3(8Z,11Z,14Z)/0:0)
LysoPA(20:3(8Z,11Z,14Z)/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. LysoPA(20:3(8Z,11Z,14Z)/0:0), in particular, consists of one chain of dihomo-gamma-linolenic acid at the C-1 position. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes.
(6R)-6-(2-Hydroxy-2-methylpropyl)-3-[(1R)-1-[4-(1-methyl-2-oxopyridin-4-yl)phenyl]ethyl]-6-phenyl-1,3-oxazinan-2-one
(1aR,2E,4aR,6S,7S,7aR,8R,11aS)-1,1,3,6-Tetramethyl-9-methylene-4-oxo-1,1a,4,5,6,7,7a,8,9,10,11,11a-dodecahydro-4aH-cyclopenta[a]cyclopropa[f][11]annulene-4a,7,8-triyl triacetate
Daigredorigenin|daigredorigenin 3-acetate|daigredorigenin-3-acetate
3beta-angeloyloxy-6beta-(3-methylpentanoyloxy)furanoeremophilan-14-oic acid
6alpha,12,18-triacetoxy-7beta-hydroxyabieta-8,11,13-triene|fortunin G
methyl-9beta-senecioyloxy-14-O-senecioyl-oxyphylloate
14-Acetoxy-2-butanoyloxy-11,12-epoxy-5,8(17)-briaradien-18,7-olide
irciformonin F|rel-(5R)-5-[(1S,4E,8E)-1,6-bis(acetyloxy)-11-(furan-3-yl)-4,8-dimethylundeca-4,8-dien-1-yl]dihydro-5-methylfuran-2(3H)-one
preaustinoid A1
A meroterpenoid found in Penicillium rubrum and Penicillium species. It has been found to exhibit inhibitory activity against the production of interleukin 1-beta from induced inflammasomes.
ent-1alpha,7beta,14alpha-triacetoxy-kaur-16-en-15-one
10-hydroxy-11,12,16-triacetoxyl-8,11,13-icetexatriene|icetexatriene-1
6alpha-acetoxy-7beta-isobutyroyloxy-8beta-hydroxy-3,10(E),13-neocleroden-15,16-olide|scutebata T
(3beta,7alpha,14beta)-3,7,14-tris(acetyloxy)-ent-kaur-16-en-15-one
7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((R)-3-hydroxy-5-(3-(trifluoromethyl)phenyl)pentyl)cyclopentyl)heptanoic acid
4beta-deoxyphorbol 12-acetate-13-isobutyrate (4-dPE B) / isolated from Euphorbia amygdaloides ssp semiperfoliata
4-[5-[[4-[5-[acetyl(hydroxy)amino]pentylamino]-4-oxobutanoyl]-hydroxyamino]pentylamino]-4-oxobutanoic acid
C26H36O7_4H-Cyclopenta[a]cyclopropa[f]cycloundecen-4-one, 4a,7,8-tris(acetyloxy)-1,1a,4a,5,6,7,7a,8,9,10,11,11a-dodecahydro-1,1,3,6-tetramethyl-9-methylene-, (1aR,2E,4aR,6S,7S,7aR,8R,11aS)
(1R,3E,5R,7S,11R,12R,13S,14S)-1,13-bis(acetyloxy)-3,6,6,14-tetramethyl-10-methylidene-2-oxotricyclo[10.3.0.0⁵,⁷]pentadec-3-en-11-yl acetate
4-[5-[[4-[5-[acetyl(hydroxy)amino]pentylamino]-4-oxobutanoyl]-hydroxyamino]pentylamino]-4-oxobutanoic acid
4-[5-[[4-[5-[acetyl(hydroxy)amino]pentylamino]-4-oxobutanoyl]-hydroxyamino]pentylamino]-4-oxobutanoic acid [IIN-based: Match]
4-[5-[[4-[5-[acetyl(hydroxy)amino]pentylamino]-4-oxobutanoyl]-hydroxyamino]pentylamino]-4-oxobutanoic acid [IIN-based on: CCMSLIB00000845587]
(1R,3E,5R,7S,11R,12R,13S,14S)-1,13-bis(acetyloxy)-3,6,6,14-tetramethyl-10-methylidene-2-oxotricyclo[10.3.0.0⁵,⁷]pentadec-3-en-11-yl acetate_major
(1R,3E,5R,7S,11R,12R,13S,14S)-1,13-bis(acetyloxy)-3,6,6,14-tetramethyl-10-methylidene-2-oxotricyclo[10.3.0.0?,?]pentadec-3-en-11-yl acetate
Ala Gly Lys Trp
Ala Gly Trp Lys
Ala Lys Gly Trp
Ala Lys Trp Gly
Ala Asn Arg Thr
Ala Asn Thr Arg
Ala Gln Arg Ser
Ala Gln Ser Arg
Ala Arg Asn Thr
Ala Arg Gln Ser
Ala Arg Ser Gln
Ala Arg Thr Asn
Ala Ser Gln Arg
Ala Ser Arg Gln
Ala Thr Asn Arg
Ala Thr Arg Asn
Ala Trp Gly Lys
Ala Trp Lys Gly
Asp Ile Ile Thr
Asp Ile Leu Thr
Asp Ile Thr Ile
Asp Ile Thr Leu
Asp Leu Ile Thr
Asp Leu Leu Thr
Asp Leu Thr Ile
Asp Leu Thr Leu
Asp Thr Ile Ile
Asp Thr Ile Leu
Asp Thr Leu Ile
Asp Thr Leu Leu
Glu Ile Ile Ser
Glu Ile Leu Ser
Glu Ile Ser Ile
Glu Ile Ser Leu
Glu Ile Thr Val
Glu Ile Val Thr
Glu Leu Ile Ser
Glu Leu Leu Ser
Glu Leu Ser Ile
Glu Leu Ser Leu
Glu Leu Thr Val
Glu Leu Val Thr
Glu Ser Ile Ile
Glu Ser Ile Leu
Glu Ser Leu Ile
Glu Ser Leu Leu
Glu Thr Ile Val
Glu Thr Leu Val
Glu Thr Val Ile
Glu Thr Val Leu
Glu Val Ile Thr
Glu Val Leu Thr
Glu Val Thr Ile
Glu Val Thr Leu
Phe Pro Pro Thr
Phe Pro Thr Pro
Phe Thr Pro Pro
Gly Ala Lys Trp
Gly Ala Trp Lys
Gly Lys Ala Trp
Gly Lys Trp Ala
Gly Gln Arg Thr
Gly Gln Thr Arg
Gly Arg Gln Thr
Gly Arg Thr Gln
Gly Thr Gln Arg
Gly Thr Arg Gln
Gly Trp Ala Lys
Gly Trp Lys Ala
Ile Asp Ile Thr
Ile Asp Leu Thr
Ile Asp Thr Ile
Ile Asp Thr Leu
Ile Glu Ile Ser
Ile Glu Leu Ser
Ile Glu Ser Ile
Ile Glu Ser Leu
Ile Glu Thr Val
Ile Glu Val Thr
Ile Ile Asp Thr
Ile Ile Glu Ser
Ile Ile Ser Glu
Ile Ile Thr Asp
Ile Leu Asp Thr
Ile Leu Glu Ser
Ile Leu Ser Glu
Ile Leu Thr Asp
Ile Met Pro Thr
Ile Met Thr Pro
Ile Pro Met Thr
Ile Pro Thr Met
Ile Ser Glu Ile
Ile Ser Glu Leu
Ile Ser Ile Glu
Ile Ser Leu Glu
Ile Thr Asp Ile
Ile Thr Asp Leu
Ile Thr Glu Val
Ile Thr Ile Asp
Ile Thr Leu Asp
Ile Thr Met Pro
Ile Thr Pro Met
Ile Thr Val Glu
Ile Val Glu Thr
Ile Val Thr Glu
Lys Ala Gly Trp
Lys Ala Trp Gly
Lys Gly Ala Trp
Lys Gly Trp Ala
Lys Trp Ala Gly
Lys Trp Gly Ala
Leu Asp Ile Thr
Leu Asp Leu Thr
Leu Asp Thr Ile
Leu Asp Thr Leu
Leu Glu Ile Ser
Leu Glu Leu Ser
Leu Glu Ser Ile
Leu Glu Ser Leu
Leu Glu Thr Val
Leu Glu Val Thr
Leu Ile Asp Thr
Leu Ile Glu Ser
Leu Ile Ser Glu
Leu Ile Thr Asp
Leu Leu Asp Thr
Leu Leu Glu Ser
Leu Leu Ser Glu
Leu Leu Thr Asp
Leu Met Pro Thr
Leu Met Thr Pro
Leu Pro Met Thr
Leu Pro Thr Met
Leu Ser Glu Ile
Leu Ser Glu Leu
Leu Ser Ile Glu
Leu Ser Leu Glu
Leu Thr Asp Ile
Leu Thr Asp Leu
Leu Thr Glu Val
Leu Thr Ile Asp
Leu Thr Leu Asp
Leu Thr Met Pro
Leu Thr Pro Met
Leu Thr Val Glu
Leu Val Glu Thr
Leu Val Thr Glu
Met Ile Pro Thr
Met Ile Thr Pro
Met Leu Pro Thr
Met Leu Thr Pro
Met Pro Ile Thr
Met Pro Leu Thr
Met Pro Thr Ile
Met Pro Thr Leu
Met Thr Ile Pro
Met Thr Leu Pro
Met Thr Pro Ile
Met Thr Pro Leu
Asn Ala Arg Thr
Asn Ala Thr Arg
Asn Arg Ala Thr
Asn Arg Thr Ala
Asn Thr Ala Arg
Asn Thr Arg Ala
Pro Phe Pro Thr
Pro Phe Thr Pro
Pro Ile Met Thr
Pro Ile Thr Met
Pro Leu Met Thr
Pro Leu Thr Met
Pro Met Ile Thr
Pro Met Leu Thr
Pro Met Thr Ile
Pro Met Thr Leu
Pro Pro Phe Thr
Pro Pro Thr Phe
Pro Thr Phe Pro
Pro Thr Ile Met
Pro Thr Leu Met
Pro Thr Met Ile
Pro Thr Met Leu
Pro Thr Pro Phe
Gln Ala Arg Ser
Gln Ala Ser Arg
Gln Gly Arg Thr
Gln Gly Thr Arg
Gln Arg Ala Ser
Gln Arg Gly Thr
Gln Arg Ser Ala
Gln Arg Thr Gly
Gln Ser Ala Arg
Gln Ser Arg Ala
Gln Thr Gly Arg
Gln Thr Arg Gly
Arg Ala Asn Thr
Arg Ala Gln Ser
Arg Ala Ser Gln
Arg Ala Thr Asn
Arg Gly Gln Thr
Arg Gly Thr Gln
Arg Asn Ala Thr
Arg Asn Thr Ala
Arg Gln Ala Ser
Arg Gln Gly Thr
Arg Gln Ser Ala
Arg Gln Thr Gly
Arg Ser Ala Gln
Arg Ser Gln Ala
Arg Thr Ala Asn
Arg Thr Gly Gln
Arg Thr Asn Ala
Arg Thr Gln Gly
Ser Ala Gln Arg
Ser Ala Arg Gln
Ser Glu Ile Ile
Ser Glu Ile Leu
Ser Glu Leu Ile
Ser Glu Leu Leu
Ser Ile Glu Ile
Ser Ile Glu Leu
Ser Ile Ile Glu
Ser Ile Leu Glu
Ser Leu Glu Ile
Ser Leu Glu Leu
Ser Leu Ile Glu
Ser Leu Leu Glu
Ser Gln Ala Arg
Ser Gln Arg Ala
Ser Arg Ala Gln
Ser Arg Gln Ala
Thr Ala Asn Arg
Thr Ala Arg Asn
Thr Asp Ile Ile
Thr Asp Ile Leu
Thr Asp Leu Ile
Thr Asp Leu Leu
Thr Glu Ile Val
Thr Glu Leu Val
Thr Glu Val Ile
Thr Glu Val Leu
Thr Phe Pro Pro
Thr Gly Gln Arg
Thr Gly Arg Gln
Thr Ile Asp Ile
Thr Ile Asp Leu
Thr Ile Glu Val
Thr Ile Ile Asp
Thr Ile Leu Asp
Thr Ile Met Pro
Thr Ile Pro Met
Thr Ile Val Glu
Thr Leu Asp Ile
Thr Leu Asp Leu
Thr Leu Glu Val
Thr Leu Ile Asp
Thr Leu Leu Asp
Thr Leu Met Pro
Thr Leu Pro Met
Thr Leu Val Glu
Thr Met Ile Pro
Thr Met Leu Pro
Thr Met Pro Ile
Thr Met Pro Leu
Thr Asn Ala Arg
Thr Asn Arg Ala
Thr Pro Phe Pro
Thr Pro Ile Met
Thr Pro Leu Met
Thr Pro Met Ile
Thr Pro Met Leu
Thr Pro Pro Phe
Thr Gln Gly Arg
Thr Gln Arg Gly
Thr Arg Ala Asn
Thr Arg Gly Gln
Thr Arg Asn Ala
Thr Arg Gln Gly
Thr Val Glu Ile
Thr Val Glu Leu
Thr Val Ile Glu
Thr Val Leu Glu
Val Glu Ile Thr
Val Glu Leu Thr
Val Glu Thr Ile
Val Glu Thr Leu
Val Ile Glu Thr
Val Ile Thr Glu
Val Leu Glu Thr
Val Leu Thr Glu
Val Thr Glu Ile
Val Thr Glu Leu
Val Thr Ile Glu
Val Thr Leu Glu
Trp Ala Gly Lys
Trp Ala Lys Gly
Trp Gly Ala Lys
Trp Gly Lys Ala
Trp Lys Ala Gly
Trp Lys Gly Ala
17-trifluoromethylphenyl-13,14-dihydro trinor Prostaglandin F1&alpha
Hydrocortisone
D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07A - Corticosteroids, plain > D07AC - Corticosteroids, potent (group iii) C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
Entereg
C78272 - Agent Affecting Nervous System > C681 - Opiate Antagonist D005765 - Gastrointestinal Agents Alvimopan dihydrate (ADL 8-2698 dihydrate) is a potent, selective, orally active and reversible μ-opioid receptor antagonist, with an IC50 of 1.7 nM. Alvimopan dihydrate has selectivity for μ-opioid receptor (Ki=0.47 nM) over κ- and δ-opioid receptors (Kis=100, 12 nM, respectively). Alvimopan dihydrate can be used for the research of postoperative ileus[1][2][3].
(S,Z)-5-Amino-2-(dibenzylamino)-1,6-diphenylhex-4-en-3-one
Taselisib
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2152 - Phosphatidylinositide 3-Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor
Gusacitinib
C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor
Acetylphenylalanyl-prolyl-boroarginine
D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D006401 - Hematologic Agents > D005343 - Fibrinolytic Agents D050299 - Fibrin Modulating Agents D002317 - Cardiovascular Agents
17-trifluoromethylphenyl-13,14-dihydro trinor Prostaglandin F1alpha
methyl (1R,2S,5S,11S,12S,14R,16S)-16-hydroxy-2,6,6,11,14,16-hexamethyl-18-methylidene-8,15,17-trioxo-7-oxatetracyclo[12.3.1.02,12.05,11]octadecane-1-carboxylate
1-[[2-(4-chlorophenyl)-5-methyl-4-oxazolyl]methyl]-N-[2-(dipropylamino)ethyl]-4-piperidinecarboxamide
N-[(S)-[(1S,2R)-1-methyl-2-[(2R)-1-[(5-methyl-2-furanyl)methylamino]-1-oxopropan-2-yl]cyclopropyl]-phenylmethyl]carbamic acid (phenylmethyl) ester
(2S)-2-[(4R,5S)-4-methyl-8-(2-methylphenyl)-5-[[methyl(propyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2S)-2-[(4R,5R)-4-methyl-8-(2-methylphenyl)-5-[[methyl(propyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2R)-2-[(4S,5S)-4-methyl-8-(4-methylphenyl)-5-[[methyl(propyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
2-cyclopropyl-1-[(1S)-1-(hydroxymethyl)-7-methoxy-9-methyl-1-(pyridin-4-ylmethyl)-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]ethanone
2-cyclopropyl-1-[(1R)-1-(hydroxymethyl)-7-methoxy-9-methyl-1-(pyridin-4-ylmethyl)-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]ethanone
(2R)-2-[(4S,5R)-4-methyl-8-(2-methylphenyl)-5-[[methyl(propyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2R)-2-[(4R,5S)-4-methyl-8-(2-methylphenyl)-5-[[methyl(propyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2S)-2-[(4S,5R)-4-methyl-8-(2-methylphenyl)-5-[[methyl(propyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
[(1R,3E,5R,7S,11R,12R,13S,14S)-1,11-diacetyloxy-3,6,6,14-tetramethyl-10-methylidene-2-oxo-13-tricyclo[10.3.0.05,7]pentadec-3-enyl] acetate
[(1R,2R,6S,10S,11R,13S,14R,15R)-14-acetyloxy-1-hydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyl-5-oxo-13-tetracyclo[8.5.0.02,6.011,13]pentadeca-3,8-dienyl] 2-methylpropanoate
(2-hydroxy-3-phosphonooxypropyl) (11Z,14Z,17Z)-icosa-11,14,17-trienoate
[(1s,2s,3s,4r,4ar,8ar)-3,4-bis(acetyloxy)-1-[2-(furan-3-yl)ethyl]-2,4a,5-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl]methyl acetate
14-(acetyloxy)-2-hydroxy-4,9,13,17-tetramethyl-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadeca-3,8,16-trien-12-yl butanoate
(8r,9s,10s)-8-ethoxy-3,4,5,14,15,16-hexamethoxy-9,10-dimethyltricyclo[10.4.0.0²,⁷]hexadeca-1(12),2,4,6,13,15-hexaene
[(2r,3r,3ar,5r,6r,7s,9bs,10ar)-2-(acetyloxy)-7-ethenyl-5,6-dihydroxy-3,7-dimethyl-4-oxo-1h,2h,3ah,5h,6h,8h,9h,10h,10ah-cyclopropa[f]phenanthren-3-yl]methyl 2-methylpropanoate
(1e,5r,10s,12z,14s,16r,17r,20s)-9-isopropyl-8,16-dimethoxy-2,5,13,16-tetramethyl-6,15,19-trioxatetracyclo[12.5.1.0⁵,¹⁰.0¹⁷,²⁰]icosa-1,8,12-triene-7,18-dione
(2s,6r)-6-[(3s,11ar,11br)-5-[(3s)-3-amino-3-carboxypropyl]-3-carboxy-1h,2h,3h,10h,11h,11ah,11bh-pyrido[2,1-f]1,6-naphthyridin-9-yl]piperidine-2-carboxylic acid
methyl (3e,3as,5ar,6r,7r,9ar,9br)-7-(acetyloxy)-3-[(3e)-5-methoxy-5-oxopent-3-en-2-ylidene]-3a,6,9a-trimethyl-2-oxo-octahydrocyclopenta[a]naphthalene-6-carboxylate
1-[(1r,4as,11ar)-1-(acetyloxy)-7-methyl-11-methylidene-1h,4ah,5h,6h,9h,10h,11ah-cyclonona[c]pyran-4-yl]-3-(acetyloxy)-4-methylpent-4-en-1-yl acetate
[(1as,1bs,3r,3ar,5s,7br,9r,9ar)-3,9-bis(acetyloxy)-5,7b-dimethyl-5-[(2s)-oxiran-2-yl]-1h,1bh,2h,3h,3ah,4h,6h,8h,9h,9ah-cyclopropa[a]phenanthren-1a-yl]methyl acetate
3-[(15-hydroxyhexadecyl)oxy]-5-methyl-1h,8h,8ah-3λ⁵-furo[3,4-e][1,3,2]dioxaphosphepine-3,6-dione
[3,4-bis(acetyloxy)-1-[2-(furan-3-yl)ethyl]-2,4a,5-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl]methyl acetate
(2r*,3s*,4r*,5r*,9s*,11s*,15r*)-3,5,15-triacetoxy-14-oxola-thyra-6(17),12e-diene
{"Ingredient_id": "HBIN006477","Ingredient_name": "(2r*,3s*,4r*,5r*,9s*,11s*,15r*)-3,5,15-triacetoxy-14-oxola-thyra-6(17),12e-diene","Alias": "NA","Ingredient_formula": "C26H36O7","Ingredient_Smile": "CC1CC2(C(C1OC(=O)C)C(C(=C)CCC3C(C3(C)C)C=C(C2=O)C)OC(=O)C)OC(=O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "21514","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
5β-hydroxybufotalin
{"Ingredient_id": "HBIN011472","Ingredient_name": "5\u03b2-hydroxybufotalin","Alias": "NA","Ingredient_formula": "C26H36O7","Ingredient_Smile": "CC(=O)OC1CC2(C3CCC4(CC(CCC4(C3CCC2(C1C5=COC(=O)C=C5)C)C)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "9860","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
9α-hydroxy-2α,10β,13α-triacetoxytaxa-4(20),5(6),11(12)-triene
{"Ingredient_id": "HBIN014045","Ingredient_name": "9\u03b1-hydroxy-2\u03b1,10\u03b2,13\u03b1-triacetoxytaxa-4(20),5(6),11(12)-triene","Alias": "NA","Ingredient_formula": "C26H36O7","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10780","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}